Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
Clinical trial NCT04543591 · COMPLETED
Trial details
- NCT number
- NCT04543591
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2025-09-19
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.